Glaucoma
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-06-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:28
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Glaucoma Formulated for associated symptoms such as increased intraocular pressure, swelling of eyes, atrophy of optic nerve and narrow field of vision.
DOSAGE & ADMINISTRATION SECTION
Directions: ORAL USE ONLY - SHAKE WELL. Adults, take 6 drops orally one to four times daily or as directed by a healthcare professional. Warning: Continue to monitor intraocular pressure. Uncontrolled glaucoma can result in blindness.
ACTIVE INGREDIENT SECTION
Aconitum nap. 15x, Aur. met. 15x, Belladonna 15x, Causticum 15x, Cinchona 15x, Colchicum 15x, Euphrasia 15x, Gelsemium 15x, Nux vom. 15x, Osmium metallicum 15x, Phosphorus 15x, Physostigma 15x, Rhus toxicodendron 15x, Spigelia anth. 15x, Euphrasia 3x.
PURPOSE SECTION
Formulated for associated symptoms such as increased intraocular pressure, swelling of eyes, atrophy of optic nerve and narrow field of vision.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: USP Purified Water; USP Gluten-free, non-GMO, organic cane dispensing alcohol 20%.
QUESTIONS? SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-4580-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b647-f424-e053-dadaa90a57ce | Glaucoma |
| 55714-4580-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b647-f424-e053-dadaa90a57ce | Glaucoma |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-4580-1 | Glaucoma | 29.57 mL in 1 BOTTLE, GLASS | LIQUID | 29.57 | 3 | |
| 55714-4580-2 | Glaucoma | 59.14 mL in 1 BOTTLE, GLASS | LIQUID | 59.14 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-4580 | GLAUCOMA (ACONITUM NAP., AUR. MET., BELLADONNA, CAUSTICUM, CINCHONA, COLCHICUM, EUPHRASIA, GELSEMIUM, NUX VOM., OSMIUM METALLICUM, PHOSPHORUS, PHYSOSTIGMA, RHUS TOXICODENDRON, SPIGELIA ANTH.) LIQUID [NEWTON LABORATORIES, INC.] | 3 | Legacy NDC, 2 package rows | 20140211_920158ec-fee7-5e2b-0bcd-e56d3d0effde.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 3 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 3 | |
| Causticum | ACTIVE INGREDIENT | DD5FO1WKFU | 3 | |
| Cinchona Officinalis Bark | ACTIVE INGREDIENT | S003A158SB | 3 | |
| Colchicum Autumnale Bulb | ACTIVE INGREDIENT | 993QHL78E6 | 3 | |
| Euphrasia Stricta | ACTIVE INGREDIENT | C9642I91WL | 3 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 3 | |
| Gold | ACTIVE INGREDIENT | 79Y1949PYO | 3 | |
| Osmium | ACTIVE INGREDIENT | 2E7M255OPY | 3 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 3 | |
| Physostigma Venenosum Seed | ACTIVE INGREDIENT | CJV9E9IIOA | 3 | |
| Spigelia Anthelmia | ACTIVE INGREDIENT | WYT05213GE | 3 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 3 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 3 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 3 | |
| Causticum | ACTIVE MOIETY | DD5FO1WKFU | 3 | |
| Cinchona Officinalis Bark | ACTIVE MOIETY | S003A158SB | 3 | |
| Colchicum Autumnale Bulb | ACTIVE MOIETY | 993QHL78E6 | 3 | |
| Euphrasia Stricta | ACTIVE MOIETY | C9642I91WL | 3 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 3 | |
| Gold | ACTIVE MOIETY | 79Y1949PYO | 3 | |
| Osmium | ACTIVE MOIETY | 2E7M255OPY | 3 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 3 | |
| Physostigma Venenosum Seed | ACTIVE MOIETY | CJV9E9IIOA | 3 | |
| Spigelia Anthelmia | ACTIVE MOIETY | WYT05213GE | 3 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 3 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 3 |
Products#
Every source-derived product name is available through these pages.
- Glaucoma
- Aconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth.
- Aconitum Napellus
- Gold
- Atropa Belladonna
- Causticum
- Cinchona Officinalis Bark
- Colchicum Autumnale Bulb
- Euphrasia Stricta
- Gelsemium Sempervirens Root
- Strychnos Nux-vomica Seed
- Osmium
- Phosphorus
- Physostigma Venenosum Seed
- Toxicodendron Pubescens Leaf
- Spigelia Anthelmia
- Alcohol
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-4580 | 55714-4580-1, 55714-4580-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Aconitum Napellus | U0NQ8555JD | ACTIB |
| Gold | 79Y1949PYO | ACTIB |
| Atropa Belladonna | WQZ3G9PF0H | ACTIB |
| Causticum | DD5FO1WKFU | ACTIB |
| Cinchona Officinalis Bark | S003A158SB | ACTIB |
| Colchicum Autumnale Bulb | 993QHL78E6 | ACTIB |
| Euphrasia Stricta | C9642I91WL | ACTIB |
| Gelsemium Sempervirens Root | 639KR60Q1Q | ACTIB |
| Strychnos Nux-vomica Seed | 269XH13919 | ACTIB |
| Osmium | 2E7M255OPY | ACTIB |
| Phosphorus | 27YLU75U4W | ACTIB |
| Physostigma Venenosum Seed | CJV9E9IIOA | ACTIB |
| Toxicodendron Pubescens Leaf | 6IO182RP7A | ACTIB |
| Spigelia Anthelmia | WYT05213GE | ACTIB |
| Alcohol | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| de802f71-3f9a-deab-91dc-a5d2709721b7 | 920158ec-fee7-5e2b-0bcd-e56d3d0effde | 2011-06-01 | Warnings | de802f71-3f9a-deab-91dc-a5d2709721b7 920158ec-fee7-5e2b-0bcd-e56d3d0effde |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
